Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma

Eur J Nucl Med Mol Imaging. 2023 May;50(6):1833-1834. doi: 10.1007/s00259-022-06061-8. Epub 2022 Dec 16.
No abstract available

MeSH terms

  • Humans
  • Iodine Radioisotopes* / therapeutic use
  • Protein Kinase Inhibitors / therapeutic use
  • Proto-Oncogene Proteins c-ret* / antagonists & inhibitors
  • Proto-Oncogene Proteins c-ret* / genetics
  • Pyrazoles* / therapeutic use
  • Pyridines* / therapeutic use
  • Thyroid Neoplasms* / drug therapy
  • Thyroid Neoplasms* / genetics
  • Thyroid Neoplasms* / pathology
  • Thyroid Neoplasms* / radiotherapy

Substances

  • Iodine Radioisotopes
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-ret
  • Pyrazoles
  • Pyridines
  • RET protein, human
  • selpercatinib